20537 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having three or more nucleosides or nucleotides Double-stranded nucleic acids or oligonucleotides
Compositions and methods for treatment of prostate and other cancers
#3602Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
#3603APOPTOSIS-INDUCING AGENT
#3604PARP-1 INHIBITORS
#3605RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases
#3606INHIBITION OF THE RENIN-ANGIOTENSIN SYSTEM FOR THE TREATMENT OF RENAL, VASCULAR AND CARTILAGE PATHOLOGY
#3607Stabilized STAT3 decoy oligonucleotides and uses therefore
#3608COMPOSITIONS AND METHODS FOR THE PREVENTION OR TREATMENT OF DIABETIC COMPLICATIONS
#3609Treatment of B Cell Lymphomas
#3610Cancer stem cell isolation
#3611Compositions and Methods for Increasing Stress Resilience
#3612Modulation of TMPRSS6 expression
#3613COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS
#3614Method of forming non-immunogenic hydrophobic protein nanoparticles, and uses therefor
#3615Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases
#3616Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8
#3617PAR-1 Antagonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections
#3618METHODS FOR DIAGNOSING AND TREATING MYHRE SYNDROME
#3619COMBINATION CANCER TREATMENTS UTILIZING SYNTHETIC OLIGONUCLEOTIDES AND EGFR-TKI INHIBITORS
#3620EDIBLE PLANT-DERIVED MICROVESICLE COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF DISEASE
#3621Telomerase mediated telomere altering compounds
#3622Methods and compositions for treating or preventing pruritis
#3623Cysteine Peptide-Containing Health Drink
#3624Compositions and methods for nucleic acid delivery
#3625Compositions and methods for dengue virus chimeric constructs in vaccines
#3626Compositions and methods for cancer and cancer stem cell detection and elimination
#3627Inhibitors of metastasis
#3628MCPIP protection against osteoclast production
#3629Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin
#3630POROUS NANOPARTICLE SUPPORTED LIPID NANOSTRUCTURES
#3631Inhibition of oncogenic kras-induced GM-CSF production and function
#3632Composition for promoting apoptosis or inhibiting cell growth, comprising epstein-barr virus microrna
#3633Pulmonary delivery of mRNA
#3634MRNA therapy for Fabry disease
#3635Cationic lipids for therapeutic agent delivery formulations
#3636Temperature sensitive liposome including cationic lipid and use thereof
#3637Compositions for delivery of cargo such as drugs proteins and/or genetic materials
#3638Synthetic nanostructures including nucleic acids and/or other entities
#3639Regeneration of Pancreatic Islets and Reversal of Diabetes by Islet Transcription Factor Genes Delivered In Vivo
#3640Method for identifying and treating a patient having tumor lesions comprising administering a gene therapy retroviral vector particle comprising a mutated HSV-thymidine kinase (HSV-TK) polynucleotide
#3641Thymidine kinase gene
#3642Methods of treating cancer
#3643Lipid Formulated Compositions and Methods for Inhibiting Expression of Eg5 And VEGF Genes
#3644Preventive or therapeutic agent for fibrosis
#3645Hepatitis B virus-binding polypeptides and methods of use thereof
#3646Methods and compositions for the treatment of cancer or other diseases
#3647Use of inhibitors of leukotriene B4 receptor BLT2 for treating asthma
#3648Pharmaceutical formulation for reducing frequency of urination and method of use thereof
#3649Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)
#3650Methods of treating allergic inflammatory conditions by administering an anti-cadherin-like 26-based therapeutic
#3651Sonochemical induction of ABCA1 expression and compositions therefor
#3652Method of controlling coagulation
#3653CYTOSINE DEAMINASE MODULATORS FOR ENHANCEMENT OF DNA TRANSFECTION
#3654MicroRNA-based approach to treating malignant pleural mesothelioma
#3655Uses of the human ZFX gene and drugs associated with same
#3656Compositions and methods for treating cancer
#3657COMPOSITIONS AND TREATMENTS BASED ON CADHERIN MODULATION
#3658Conserved HBV and HCV sequences useful for gene silencing
#3659METHODS OF USE OF GLUTAMINE SYNTHETASE INHIBITORS
#3660Targeting CLPTM1L by RNA interference for treatment and prevention of cancer
#3661Increasing parkin activity by administering a deubiquitinating enzyme inhibitor
#3662Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration
#3663MEDICAMENT FOR DISEASES ASSOCIATED WITH AMYLOID beta AND SCREENING THEREOF
#3664Compounds for the treatment of ischemic injury
#3665Compositions and methods for treatment of mitochondrial diseases
#3666Diagnosis and treatment of cancers with microrna located in or near cancer-associated chromosomal features
#3667Compositions and Methods for Delivery of High-Affinity Oxygen Binding Agents to Tumors
#3668PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA
#3669Pulmonary hypertension
#3670Tumor Selective Chemokine Modulation
#3671Nanoparticles stabilized with nitrophenylboronic acid compositions
#3672Targeted nanoparticles
#3673MULTIPLE EMULSION
#3674Manganese ion coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation
#3675Compositions and methods for silencing aldehyde dehydrogenase
#3676Modulation of Cellular Migration
#3677CXCR4 inhibiting carriers for nucleic acid delivery
#3678SPRAY SYSTEM FOR PRODUCTION OF A MATRIX FORMED IN SITU
#3679Methods for promoting entry of an agent into a cell
#3680KRT19 stabilizing HER2 and use thereof
#3681Therapeutic nanoparticles and methods of use thereof
#3682METHODS AND COMPOSITIONS FOR TREATING ATRIAL FIBRILLATION
#3683Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells
#3684Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity
#3685Modulation of HSP47 expression
#3686Composition for prevention or treatment of ischemic cardiac disease, comprising inhibitor against age-albumin synthesis or release of mononuclear phagocyte system cells as active ingredient
#3687Method for decreasing radioresistance and growth, metastasis and infiltration of cancer cells through regulating expression or activity of TM4SF4 in non-small cell lung cancer
#3688Treatment of heart failure and related conditions
#3689Albumin production and cell proliferation
#3690Cell penetrating peptides for intracellular delivery of molecules
#3691Gpr177 as target and marker in tumors
#3692Antibody-SN-38 immunoconjugates with a CL2A linker
#3693Methods for heart regeneration
#3694NUCLEIC ACID MOLECULES AND USES THEREOF
#3695Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
#3696Ameliorating oxidative stress in neurodegenerative disease via Nox1 targeting
#3697Method and medicament for inhibiting the expression of a given gene
#3698Methods for treating Niemann-Pick type C disease
#3699Method and medicament for inhibiting the expression of a given gene
#3700NOVEL COCHLEATE FORMULATIONS
#3701DDR2 mutations as targetable features of melanoma or basal cell carcinoma
#3702Method of inhibiting cancer in a mammal by administering an antibody to PTHrP
#3703COMPOSITIONS AND METHODS FOR TREATING PAIN
#3704MHC ENGAGEMENT AND CLIP MODULATION FOR THE TREATMENT OF DISEASE
#3705METHODS FOR INDUCING CARDIOMYOCYTE PROLIFERATION
#3706Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
#3707HCV Combination Therapy
#3708METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING LYMPHOID MALIGNANCY
#3709MOLECULAR TARGETS FOR HEALING OR TREATING WOUNDS
#3710Methods for treatment of cancer by targeting Sirt5
#3711DELIVERY SYSTEM
#3712Oil-in-water emulsions that contain nucleic acids
#3713TREATMENT OF LEUKEMIA
#3714Sustained-release lipid pre-concentrate of pharmacologically active substance and pharmaceutical composition comprising the same
#3715Siglec-15 antibodies in treating bone loss-related disease
#3716Pharmaceutical combination comprising a CIP2A silencing agent for use in the treatment of a hyperproliferative disorder, preferably one with impaired p53 function
#3717COMPOSITIONS AND METHODS FOR INHIBITING TUMOR DEVELOPMENT CAUSED BY CHEMOTHERAPY INDUCED SENESCENCE
#3718Liposomes comprising polymer-conjugated lipids and related uses
#3719Targeted therapeutic nanoparticles
#3720Compositions and methods for inhibiting expression of TMPRSS6 gene
#3721STABILISED VACCINE COMPOSITION
#3722Method of vaccination comprising a histone deacetylase inhibitor
#3723Methods used in sensitizing invasive glioblastoma to therapeutic treatment
#3724Polymalic acid-based nanobiopolymer compositions
#3725Mitochondrial ribosomal proteins as aging regulators
#3726Methods of modulating compliance of the trabecular meshwork
#3727Protection against endothelial barrier dysfunction through inhibition of the tyrosine kinase abl-related gene (ARG)
#3728MANIPULATION OF REGULATORY T CELL AND DC FUNCTION BY TARGETING NEURITIN GENE USING ANTIBODIES, AGONISTS AND ANTAGONISTS
#3729Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#3730METHODS AND COMPOSITIONS REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS
#3731Targeting lipids
#3732Modified siRNA molecules and uses thereof
#3733SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION
#3734AMPHOTERIC LIPOSOMES COMPRISING NEUTRAL LIPIDS
#3735Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway
#3736Protection of cells from -RNA-induced degeneration and inhibitors for protecting cells
#3737Theranostic imaging agents and methods of use
#3738Composition for inhibiting angiogenesis containing a peroxidasin inhibitor as an active ingredient
#3739Compositions and methods for treatment of tamoxifen resistant breast cancer
#3740Nanotubes as carriers of nucleic acids into cells
#3741USE OF A TRUNCATED EIF-5A1 POLYNUCLEOTIDE TO INDUCE APOPTOSIS IN CANCER CELLS
#3742METHODS FOR TREATING IMMUNOSUPPRESSION
#3743Uniform field magnetization and targeting of therapeutic formulations
#3744Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
#3745METHODS USEFUL IN THE PREVENTION OF HYPOXIC INJURY
#3746Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions
#3747COMPOUNDS, COMPOSITION, METHODS, TARGETS FOR CANCER THERAPY
#3748Combined inhibition of the vitamin D receptor and DNA replication in the treatment of cancer
#3749Lipids and compositions for intracellular delivery of biologically active compounds
#3750Compositions and methods for transport across the blood brain barrier
#3751Lipids and compositions for intracellular delivery of biologically active compounds
#3752Amine-containing lipidoids and uses thereof
#3753Platelet derived growth factor receptor supports cytomegalovirus infectivity
#3754METHODS FOR TREATING INFLAMMATORY AUTOIMMUNE DISORDERS
#3755Treatment of tristetraproline (TTP) related diseases by inhibition of natural antisense transcript to TTP
#3756Spinal muscular atrophy treatment via targeting SMN2 catalytic core
#3757MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF BONE AND JOINT DEGENERATIVE DISEASES
#3758Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
#3759Selective inhibitors of tumor-initiating cells
#3760TREATING CANCER BY INHIBITING EXPRESSION OF OLFM4, SP5, TOB1, ARID1A, FBN1 OR HAT1
#3761Methods of treating a metabolic syndrome by modulating heat shock protein (HSP) 90-β
#3762[N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection
#3763METHODS AND REAGENTS FOR EFFICIENT CONTROL OF HIV PROGRESSION
#3764METHODS AND COMPOSITIONS FOR THE TREATMENT OF MARFAN SYNDROME AND ASSOCIATED DISORDERS
#3765Compositions and methods for inhibiting expression of CD274/PD-L1 gene
#3766Therapeutic and diagnostic method for ataxia-telangiectasia
#3767Methods and compositions for selecting siRNA of improved functionality
#3768Compositions and methods of preventing or ameliorating abnormal thrombus formation and cardiovascular disease
#3769USE OF IL-23 ANTAGONISTS FOR TREATMENT OF INFECTION
#3770NCoR1 is a Physiological Modulator of Muscle Mass and Oxidative Function
#3771Medicament for liver regeneration and for treatment of liver failure
#3772METHOD OF FIXING AND EXPRESSING PHYSIOLOGICALLY ACTIVE SUBSTANCE
#3773TARGETING EN2, PAX2, AND/OR DEFB1 FOR TREATMENT OF PROSTATE CONDITIONS
#3774Combination therapy
#3775Nanogels
#3776Cationic lipids and methods for the delivery of therapeutic agents
#3777Individualized cancer therapy
#3778Methods for P2RY5 Mediated Regulation of Hair Growth and Mutants Thereof
#3779Composition comprising inhibitors of IRS-1 and of VEGF
#3780Use of transforming growth factor-beta neutralizing antibodies and fusion proteins thereof in treating pain
#3781Modulation of apolipoprotein CIII (ApoCIII) expression
#3782Cancer Therapy
#3783Oligonucleotide derivative, oligonucleotide derivative-containing pharmaceutical composition for treatment and pharmaceutical composition for diagnosis, and oligonucleotide derivative for regulation of miRNA function
#3784Methods and compositions for the treatment of cancer or other diseases
#3785Methods for promoting neuronal outgrowth by insulin-like growth factor binding protein-like 1 (IGFBPL-1) in glaucoma or leber's optic neuropathy
#3786Micro-RNAs and micro-RNA inhibitors to modulate blood vessel growth, patterning, tumor growth and malignant disease and method for making and using them
#3787TARGETING AGENT FOR CANCER CELL OR CANCER-ASSOCIATED FIBROBLAST
#3788HCV Combination Therapy
#3789TREATMENT FOR MUSCULAR DYSTROPHIES
#3790TREATMENT OF AUTOIMMUNE DISORDERS AND INFECTIONS USING ANTAGONISTS OF SGK1 ACTIVITY
#3791Use of carbon nanomaterials with antioxidant properties to treat oxidative stress
#3792Compositions and Methods for Diagnosing and Treating Diabetic Micro Vascular Complications
#3793ERK inhibitors for use in treating spinal muscular atrophy
#3794Mammalian receptors as targets for antibody and active vaccination therapy against mold infections
#3795Methods for inhibiting osteolysis
#3796Use of HGMA-targeted phosphorothioate DNA aptamers to suppress carcinogenic activity and increase sensitivity to chemotherapy agents in human cancer cells
#3797Organic compositions to treat Beta-ENaC-related diseases
#3798Methods and Compositions for Transdermal Delivery of Nucleotides
#3799SYNERGISTIC INHIBITION OF ERBB2/ERBB3 SIGNAL PATHWAYS IN THE TREATMENT OF CANCER
#3800Compositions and methods for treating musculoskeletal diseases and disorders
#3801Cancer treatment by combining DNA molecules mimicking double strand breaks with hyperthermia
#3802Methods of treatment relating to the FMR1 gene
#3803Methods and Compositions for Maintaining Blood-Brain Barrier Integrity
#3804Human toll-like receptor inhibitors and methods of use thereof
#3805RNAi INHIBITION OF CTGF FOR TREATMENT OF OCULAR DISORDERS
#3806ALPHA SYNUCLEIN TOXICITY
#3807METHODS OF INHIBITING TUMOR GROWTH USING TTK ANTAGONISTS
#3808Matriptase inhibitors and uses thereof against orthomyxoviridae infections
#3809Compounds for the treatment of autism in a baby child
#3810MiR-33 inhibitors and uses thereof to decrease inflammation
#3811Combination of anti-clusterin oligonucleotide with Hsp90 inhibitor for the treatment of prostate cancer
#3812COMPOSITIONS AND METHODS FOR MACROMOLECULAR DRUG DELIVERY
#3813METHODS FOR TREATING HEPATOCELLULAR CARCINOMA
#3814Vector for pulmonary delivery, inducing agent, and uses
#3815Therapeutic applications targeting SARM1
#3816Melatonin-based treatment and diagnosis of bile duct disease
#3817Method of inhibiting nonsense-mediated mRNA decay
#3818Bruton's tyrosine kinase as anti-cancer drug target
#3819Diagnostic, prognostic and therapeutic uses of long non-coding RNAs for cancer and regenerative medicine
#3820NOVEL TARGETS FOR TREATMENT OF HYPERCHOLESTEROLEMIA
#3821Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
#3822Methods and compositions for the treatment of cancer or other diseases
#3823Compositions and methods for treatment of ear disorders
#3824Prostate carcinogenesis predictor
#3825Compositions and Methods for Treating Brain Tumors
#3826Methods for treating hair loss disorders
#3827Use of Cytokine Expression to Predict Skin Inflammation; Methods of Treatment
#3828Methods for the treatment of hepatitis B and hepatitis D infections
#3829Method of screening for chaperonin modulator
#3830Metastasis specific splice variants of Mena and uses thereof in diagnosis, prognosis and treatment of tumors
#3831dsRNA for treating viral infection
#3832Compositions and methods for the treatment of cancer
#3833SIN3B COMPLEX INHIBITION AND USE THEREOF IN THE PREVENTION OF PRO-ONCOGENIC INFLAMMATION AND CANCER
#3834Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activity
#3835Composition for treating, improving, or preventing pain
#3836Methods to regulate polarization and enhance function of cells
#3837Regulator, pharmaceutical composition encompassing the regulator and application thereof
#3838Method and medicament for inhibiting the expression of a given gene
#3839Polyamine derivatives
#3840METHODS AND COMPOSITIONS FOR INHIBITING CYCLOPHILIN D FOR THE TREATMENT AND PREVENTION OF OBESITY AND KIDNEY INDICATIONS
#3841Materials and methods related to microRNA-21, mismatch repair, and colorectal cancer
#3842LIPID NANO PARTICLES COMPRISING COMBINATION OF CATIONIC LIPID
#3843Drug delivery particle and method for producing the same
#3844Method for selectively inhibiting ACAT1 in the treatment of alzheimer's disease
#3845RNAi pharmaceutical composition for suppressing expression of KRAS gene
#3846B-type plexin antagonists and uses thereof
#3847PROCOLLAGEN CARBOXY-TERMINAL PROPEPTIDES AS A TARGET AND TREATMENT FOR ANGIOGENESIS RELATED DISEASES
#3848ANKYRIN G AND MODULATORS THEREOF FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
#3849Analgesic method
#3850Organic compositions to treat HSF1-related diseases
#3851Pharmaceutical composition for treating aging-associated diseases, containing progerin expression inhibitor as active ingredient, and screening method of said progerin expression inhibitor
#3852Modulation of LRCH4 activity and therapeutic application thereof
#3853Molecular subtyping, prognosis and treatment of prostate cancer
#3854Composition comprising expression or activity inhibitors of Ninjurin1 for the prevention and treatment of inflammatory disease
#3855MODULATION OF PILR RECEPTORS TO TREAT MICROBIAL INFECTIONS
#3856CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS
#3857Regimens and Compositions for AAV-Mediated Passive Immunization of Airborne Pathogens
#3858siRNA targeting VEGFA and methods for treatment in vivo
#3859Compositions and methods for modulating angiogenesis
#3860Methods of administering D-dopachrome tautomerase (D-DT) to treat ischemia-reperfusion injury
#3861Method for treating malaria
#3862Oligonucleotide analogues targeting human LMNA
#3863Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA
#3864DISEASE INHIBITING AGENT
#3865Nanocapsules with a polymer shell
#3866Low density lipoprotein receptor-mediated siRNA delivery
#3867Particle composition and pharmaceutical composition using particle composition
#3868Method for treatment of cardiac disorders
#3869Methods for affecting homology-directed DNA double stranded break repair
#3870Use of DR6 and p75 antagonists to promote survival of cells of the nervous system
#3871Compositions and Methods for Restoring or Rejuvenating Stem/Progenitor Cell Function
#3872SiRNA against Cbl-b and optionally IL-2 and IL-12 for use in the treatment of cancer
#3873Compositions and methods for treating lung disease and injury
#3874AUTOPHAGY INDUCER AND INHIBITOR COMBINATION THERAPY FOR THE TREATMENT OF NEOPLASMS
#3875DRUG CARRIER FOR TUMOR-TARGETED THERAPY, ITS PREPARATION METHOD AND ITS USE
#3876Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75
#3877Identification and use of target genes for control of plant parasitic nematodes
#3878Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes
#3879In Vivo Delivery of Nucleic Acids to the Liver or Liver Tissue
#3880PEGYLATED POLYPLEXES FOR POLYNUCLEOTIDE DELIVERY
#3881GRAPHITE-COATED MAGNETIC NANOPARTICLES
#3882RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CONDITIONS
#3883Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activity
#3884Compositions for nucleic acid delivery
#3885Method and compositions for treating HIV infection
#3886METHODS FOR TREATING EARLY STAGE OR MILD NEUROLOGICAL DISORDERS
#3887KINASES AS TARGETS FOR ANTI-DIABETIC THERAPY
#3888HOX COMPOSITIONS AND METHODS
#3889Methods for modulating the expression and aggregation of a CAG-expanded gene product in cells and methods for identifying agents useful for doing the same
#3890Metabolic gene, enzyme, and flux targets for cancer therapy
#3891ANALGESIC MEDICATION
#3892Diagnosis and treatment of cancers with microRNA located in or near cancer-associated chromosomal features
#3893Compositions comprising gamma retrovirus vectors and methods of treating proliferative disorders
#3894METHODS AND COMPOSITIONS FOR DELIVERY OF ACTIVE AGENTS
#3895Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes
#3896METHOD OF TREATING DIABETES
#3897Methods and compositions for unsilencing imprinted genes
#3898Anti-trypanosomal peptides and uses thereof
#3899Lipid nanoparticle compositions for antisense oligonucleotides delivery
#3900Methods for the treatment of heart failure